Quantcast

Latest Epoxides Stories

2010-06-22 15:56:28

Researchers have found that increasing certain proteins in the blood vessels of mice, relaxed the vessels, lowering the animal's blood pressure. The study provides new avenues for research that may lead to new treatments for hypertension. "The paper demonstrates that cytochrome P450 plays an important role in the management of high blood pressure, a disease of enormous public health concern," said Darryl Zeldin, M.D., acting clinical director of the National Institute of Environmental Health...

2010-04-08 16:20:00

Scientists at the U.S. Department of Energy's Argonne National Laboratory have identified a new class of silver-based catalysts for the production of the industrially useful chemical propylene oxide that is both environmentally friendly and less expensive. "The production of propylene oxide has a significant amount of by-products that are harmful to the environment, including chlorinated or peroxycarboxylic waste," said chemist Stefan Vajda of Argonne's Materials Science Division and Center...

2010-02-02 07:00:00

WALTHAM, Mass., Feb. 2 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that Boehringer Ingelheim/Pfizer's Spiriva will retain Decision Resources' proprietary clinical gold standard status for the treatment of chronic obstructive pulmonary disease (COPD) through 2018. While some drugs in development for COPD hold promise, most have less favorable efficacy, safety and tolerability, and/or delivery...

2010-01-14 14:23:00

Current data do not support increased risks for stroke, heart attack, or death SILVER SPRING, Md., Jan. 14 /PRNewswire-USNewswire/ -- The U.S. Food and Drug Administration today announced that data from a recent review of the Spiriva HandiHaler, a long-acting respiratory treatment for chronic obstructive pulmonary disease (COPD), do not support an increased risk of stroke, heart attack, or death in patients using the medicine. (Logo: http://www.newscom.com/cgi-bin/prnh/20090824/FDALOGO)...

2009-10-06 10:53:00

NEW YORK, Oct. 6 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue. Reportlinker Adds Propylene Glycol: 2009 World Market Outlook And Forecast http://www.reportlinker.com/p0152025/Reportlinker-Adds-Propylene-Glycol-2009-World-Market-Outlook-And-Forecast.html The report analyzes worldwide markets for Propylene glycol, including Europe, Asia, North America, Latin America and Oceania. It provides the most complete and current...

2009-04-27 07:18:00

FAIRFIELD, N.J., April 27 /PRNewswire/ -- Medimetriks Pharmaceuticals announced today that the Company launched Centany(R) (mupirocin ointment, 2%) and Uramaxin(TM) (20% Urea) Foam to its core Dermatology and Podiatry physician audiences. Centany(R) received a New Drug Approval in December 2002 and is patented through 2018. Centany(R) represents a significant step in Medimetriks' plan to commercialize patent-protected therapies that offer important patient benefits. Uramaxin(TM) Foam...

2009-01-12 07:00:00

Spiriva Will Remain the Gold Standard Treatment Through 2017, According to a New Report from Decision Resources. WALTHAM, Mass., Jan. 12 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms focusing on pharmaceutical and healthcare issues, finds that a biologic drug that is superior to Boehringer Ingelheim/Pfizer's Spiriva in reducing yearly COPD-related exacerbations would earn a higher patient share in Europe (30 percent) than in the U.S. (15 percent)...

2008-10-06 09:00:09

Pfizer Canada and Boehringer Ingelheim, a German drug company, have announced positive results of the Uplift trial, which showed that when patients with chronic obstructive pulmonary disease received tiotropium, there was a statistically significant 16% decrease in the risk of death. The study showed sustained improvements in lung function for up to four years (p Tiotropium, a long-acting inhaled anticholinergic medication, also provided statistically significant improvements in...

2008-10-05 09:00:05

RIDGEFIELD, Conn., and NEW YORK, Oct. 5 /PRNewswire/ -- Results of the UPLIFT (Understanding Potential Long-term Impacts on Function with Tiotropium) trial, showed that SPIRIVA(R) HandiHaler(R) (tiotropium bromide inhalation powder), sustained improvements in lung function for up to 4 years as measured by FEV(1) (p UPLIFT, one of the largest COPD trials ever undertaken, is a four-year multicenter (470 sites), multinational (37 countries), randomized, double-blind, placebo-controlled,...

2008-09-24 21:00:09

Anticholinergic drugs contained in the inhalers could increase the risk of a heart attack, cardio-vascular death or stroke by more than 50 per cent, research showed.The inhalers help people with chronic obstructive pulmonary disease (COPD), which includes chronic bronchitis and emphysema, to breathe. They open up airways by relaxing muscles, to allow air in and out of the patient's lungs more easily.The latest study looked at the inhalers ipratropium (Atrovent) and tiotropium (Spiriva). The...


Word of the Day
toccata
  • In music, a work for a keyboard-instrument, like the pianoforte or organ, originally intended to utilize and display varieties of touch: but the term has been extended so as to include many irregular works, similar to the prelude, the fantasia, and the improvisation.
This word is Italian in origin, coming from the feminine past participle of 'toccare,' to touch.
Related